Exploring the Potential of Natural Products in Cancer Treatment

Anticancer Therapeutics

Volumn , Issue , 2008, Pages 1-16

  Lamari, Fotini N ^a   Cordopatis, Paul ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Anticancer drugs teniposide and etoposide; Bioactive natural products search; Combinatorial biosynthesis modifying biosynthetic pathways; Marine organisms and nuclear factor (NF) B inhibitors; Medicinal chemists and 'drug like' features; Natural product potential novel anticancer drugs; Natural products in cancer treatment; Podophyllum peltatum linnaeus and podophyllum emodii; Traditional holistic medicinal systems

Indexed keywords

EID: 84889317963     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470697047.ch1     Document Type: Chapter

References (46)

1. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci 2005, 78(5), 431-41.
2. Balachandran P, Govindarajan R. Cancer-an ayurvedic perspective. Pharmacol Res 2005, 51(1), 19-30.
3. Berdy J. Bioactive microbial metabolites: a personal view. J Antibiot 2005, 58, 1-26.
4. Boldi AM. Libraries from natural product-like scaffolds. Curr Opin Chem Biol 2004, 8, 281-286.
5. Böröczky K, Laatsch H, Wagner-Döbler I, Stritzke K, Schulz S. Cluster analysis as selection and dereplication tool for the identification of new natural compounds from large sample sets. Chem Biodivers 2006, 3(6), 622-34.
6. Connors T. Anticancer drug development: the way forward. Oncologist 1996, 1(3), 180-81.
7. Duffin J. Poisoning the spindle: serendipity and discovery of the anti-tumour properties of the Vinca alkaloids. Pharm Hist 2002, 44(2), 64-76.
8. Dunkel M, Fullbeck M, Neumann S, Preissner R. SuperNatural: a searchable database of available natural compounds. Nucleic Acids Res 2006, 34(Database issue): D678-83.
9. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18(3), 581-92.
10. Floss HG. Combinatorial biosynthesis-Potential and problems. J Biotech 2006, 124, 242-57.
11. Folmer F, Jaspars M, Dicato M, Diederich M. Marine natural products as targeted modulators of the transcription factor NF-kappaB. Biochem Pharmacol 2008, 75(3), 603-17.
12. Fredenhagen A, Derrien C, Gassmann E. An MS/MS library on an ion-trap instrument for efficient dereplication of natural products. Different fragmentation patterns for [M + H]C and [M + Na]C ions. J Nat Prod 2005, 68(3), 385-91.
13. Gordaliza M, García PA, del Corral JM, Castro MA, Gómez-Zurita MA. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 2004, 44(4), 441-59.
14. Graham JG, Quinn ML, Fabricant DS, Farnsworth NR. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. J Ethnopharmacol 2000, 73(3), 347-77.
15. Harvey AL. Natural products as a screening source. Curr Opin Chem Biol 2007, 11, 480-484.
16. Houghton PJ, Howes M-J, Lee CC, Steventon G. Uses and abuses of in vitso tests in ethnopharmacology: visualizing an elephant. J Ethnopharmacol 2007, 110, 391-400.
17. Hanahan D, Weinber R. The hallmarks of cancer. Cell 2000, 100(1), 57-70.
18. Hartwell JL. Plants used against cancer. A survey. Lloydia 1971, 34(2), 204-55.
19. Harborne JB. Twenty-five years of chemical ecology. Nat Prod Rep 2001, 18(4), 361-79.
20. Horwitz SB. Personal recollections on the early development of taxol. J Nat Prod 2004, 67(2), 136-8.
21. Jensen PR, Fenical W. Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectives. Annu Rev Microbiol 1994, 48, 559-84.
22. Julsing MK, Koulman A, Woerdenbag HJ, Quax WJ, Kayser O. Combinatorial biosynthesis of medicinal plant secondary metabolites. Biomol Eng 2006, 23(6), 265-79.
23. Jordan VC. SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst 2007, 99(5), 350-6.
24. Kingston DG, Newman DJ. Taxoids: cancer-fighting compounds from nature. Curr Opin Drug Discov Devel 2007, 10(2), 130-44.
25. López-Pérez JL, Therón R, del Olmo E, Díaz D. NAPROC-13: a database for the dereplication of natural product mixtures in bioassay-guided protocols. Bioinformatics 2007, 23(23), 3256-7.
26. Mans DR, da Rocha AB, Schwartsmann G. Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 2000, 5(3), 185-98.
27. Martinez A, Hopke J, MacNeil IA, Osburne MS. Accessing the genomes of uncultivated microbes for novel natural products. In: Natural Products: Drug Discovery and Therapeutic Medicine, edited by L Zhang and AL Demain. Humana Press Inc., Totowa, NJ, 2000.
28. McChesney JD, Venkataramans SK, Henri JT. Plant natural products: back to the future or into extinction? Phytochemistry 2007, 68, 2015-22.
29. Mishra KP, Ganju L, Sairam M, Banerjee PK, Sawhney RC. A review of high throughput technology for the screening of natural products. Biomed Pharmacother 2008, 62(2), 94-8.
30. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007, 70(3), 461-77.
31. Nicolaou KC, Yang Z, Liu JJ, et al. Total synthesis of taxol. Nature 1994, 367(6464), 630-4.
32. Pancer Z, Rast JP, Davidson EH. Origins of immunity: transcription factors and homologues of effector genes of the vertebrate immune system expressed in sea urchin coelomocytes. Immunogenetics 1999, 49, 773-86.
33. Pettit RK. Soil DNA libraries for anticancer drug discovery. Cancer Chemother Pharmacol 2004, 54, 1-6
34. Pieters LA, Vlietinck AJ. Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds? J Ethnopharmacol 2005, 100, 57-60
35. Raza M. A role for physicians in ethnopharmacology and drug discovery. J Ethnopharm 2006, 104, 297-301
36. Reddy L, Odhav B, Bhoola KD. Natural products for cancer prevention: a global perspective. Pharmacol Ther 2003, 99(1), 1-13.
37. Russo GL. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 2007, 74(4), 533-44.
38. Shi QW, Kiyota H. New natural taxane diterpenoids from Taxus species since 1999. Chem Biodivers 2005, 2(12), 1597-623.
39. Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH. Marine natural products as anticancer drugs. Mol Cancer Ther 2005, 4(2), 333-42.
40. Sriram D, Yogeeswari P, Thirumurugan R, Bal TR. Camptothecin and its analogues: a review on their chemotherapeutic potential. Nat Prod Res 2005, 19(4), 393-412.
41. Srivastava V, Negi AS, Kumar JK, Gupta MM, Khanuja SP. Plant-based anticancer molecules: a chemical and biological profile of some important leads. Bioorg Med Chem 2005, 13(21), 5892-908.
42. Subramanian B, Nakeff A, Tenney K, Crews P, Gunatilaka L, Valeriote F. A new paradigm for the development of anticancer agents from natural products. J Exp Ther Oncol 2006, 5(3), 195-204.
43. Tulp M, Bohlin L. Unconventional natural sources for future drug discovery. Drug Discov Today 2004, 9(10), 450-8.
44. von Mehren M. Trabectedin-a targeted chemotherapy? Lancet Oncol 2007, 8(7), 565-7.
45. Wall ME, Wani MC. Camptothecin and taxol: discovery to clinic-thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1995, 55(4), 753-60.
46. Zazopoulos E, Huang K, Staffa A, et al. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 2003, 21(2), 187-90.